Vascular actions of 20-HETE

O’Donnell, 2009, Eicosanoids: generation and detection in mammalian cells, Methods Mol Biol, 462, 5 Roman, 2002, P-450 metabolites of arachidonic acid in the control of cardiovascular function, Physiol Rev, 82, 131, 10.1152/physrev.00021.2001 Capdevila, 2000, Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase, J Lipid Res, 41, 163, 10.1016/S0022-2275(20)32049-6 Powell, 1998, Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11, J Pharmacol Exp Ther, 285, 1327 Lasker, 2000, Formation of 20-hydroxyeicosatetraenoic acid: a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11, J Biol Chem, 275, 4118, 10.1074/jbc.275.6.4118 Muller, 2007, Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation, Biochem J, 403, 109, 10.1042/BJ20061328 Nakagawa, 2006, Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel, J Clin Invest, 116, 1696, 10.1172/JCI27546 Kimura, 1989, The rat clofibrate-inducible CYP4A gene subfamily. I. Complete intron and exon sequence of the CYP4A1 and CYP4A2 genes: unique exon organization, and identification of a conserved 19-bp upstream element, DNA, 8, 503, 10.1089/dna.1.1989.8.503 Kimura, 1989, The rat clofibrate-inducible CYP4A subfamily. II. cDNA sequence of IVA3: mapping of the Cyp4a locus to mouse chromosome 4, and coordinate and tissue-specific regulation of the CYP4A genes, DNA, 8, 517, 10.1089/dna.1.1989.8.517 Stromstedt, 1990, Cloning and characterization of a novel member of the cytochrome P450 subfamily IVA in rat prostate, DNA Cell Biol, 9, 569, 10.1089/dna.1990.9.569 Lino Cardenas, 2012, Arachidonic acid omega-hydroxylase CYP4A11: inter-ethnic variations in the 8590T>C loss-of-function variant, Mol Biol Rep, 39, 1503, 10.1007/s11033-011-0888-x Stec, 2007, Functional polymorphism in human CYP4F2 decreases 20-HETE production, Physiol Genomics, 30, 74, 10.1152/physiolgenomics.00003.2007 Ward, 2008, A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure, Hypertension, 51, 1393, 10.1161/HYPERTENSIONAHA.107.104463 Gebremedhin, 1998, Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current, J Physiol, 507, 771, 10.1111/j.1469-7793.1998.771bs.x Williams, 2010, 20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension, J Cardiovasc Pharmacol, 56, 336, 10.1097/FJC.0b013e3181f04b1c Xu, 2004, Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes, J Pharmacol Exp Ther, 308, 887, 10.1124/jpet.103.059626 Singh, 2007, Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension, Hypertension, 50, 123, 10.1161/HYPERTENSIONAHA.107.089599 Miyata, 2005, Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system, J Smooth Muscle Res, 41, 175, 10.1540/jsmr.41.175 Harder, 1994, Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels, Am J Physiol, 266, H2098 Parmentier, 2005, Evaluation of cytochrome P450 4 family as mediator of phospholipase D activation in aortic vascular smooth muscle cells, Life Sci, 77, 1015, 10.1016/j.lfs.2005.03.002 Christmas, 2001, Alternative splicing determines the function of CYP4F3 by switching substrate specificity, J Biol Chem, 276, 38166, 10.1074/jbc.M104818200 Hill, 1992, Quantitation of 20-hydroxy-5,8,11,14-eicosatetraenoic acid (20-HETE) produced by human polymorphonuclear leukocytes using electron capture ionization gas chromatography/mass spectrometry, Biol Mass Spectrom, 21, 249, 10.1002/bms.1200210505 Rosolowsky, 1996, Metabolism of arachidonic acid by canine polymorphonuclear leukocytes synthesis of lipoxygenase and omega-oxidized metabolites, Biochim Biophys Acta, 1300, 143, 10.1016/0005-2760(95)00238-3 Tsai, 2011, 20-Hydroxyeicosatetraenoic acid synthesis is increased in human neutrophils and platelets by angiotensin II and endothelin-1, Am J Physiol Heart Circ Physiol, 300, H1194, 10.1152/ajpheart.00733.2010 Wu, 2011, The role of 20-HETE in androgen-mediated hypertension, Prostaglandins Other Lipid Mediat, 96, 45, 10.1016/j.prostaglandins.2011.06.006 Chen, 2014, 20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo, J Pharmacol Exp Ther, 348, 442, 10.1124/jpet.113.210120 Cheng, 2010, 20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling, J Pharmacol Exp Ther, 332, 57, 10.1124/jpet.109.159863 Le, 2008, Targeting genes in the renin-angiotensin system, Curr Opin Nephrol Hypertens, 17, 57, 10.1097/MNH.0b013e3282f2fd39 Cvetkovic, 2000, Understanding hypertension through genetic manipulation in mice, Kidney Int, 57, 863, 10.1046/j.1523-1755.2000.057003863.x Hercule, 2000, Cytochrome P450 omega/omega-1 hydroxylase-derived eicosanoids contribute to endothelin(A) and endothelin(B) receptor-mediated vasoconstriction to endothelin-1 in the rat preglomerular arteriole, J Pharmacol Exp Ther, 292, 1153 Oyekan, 1997, Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II, Am J Physiol, 273, R293 Oyekan, 1998, Cytochrome P-450-derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat, Am J Physiol, 274, R52 Imig, 1996, Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles, Am J Physiol, 270, R217 Carroll, 1996, Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides, Am J Physiol, 271, R863 Carroll, 1997, Cytochrome P450-derived renal HETEs: storage and release, Kidney Int, 51, 1696, 10.1038/ki.1997.234 Croft, 2000, Angiotensin II releases 20-HETE from rat renal microvessels, Am J Physiol Renal Physiol, 279, F544, 10.1152/ajprenal.2000.279.3.F544 Alonso-Galicia, 2002, Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II, Am J Physiol Regul Integr Comp Physiol, 283, R60, 10.1152/ajpregu.00664.2001 Amaral, 2003, CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis, Am J Physiol Heart Circ Physiol, 284, H1528, 10.1152/ajpheart.00406.2002 Jiang, 2004, Smooth muscle – specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels, Circ Res, 94, 167, 10.1161/01.RES.0000111523.12842.FC Muthalif, 1998, 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells, Proc Natl Acad Sci U S A, 95, 12701, 10.1073/pnas.95.21.12701 Randriamboavonjy, 2003, 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase, Hypertension, 41, 801, 10.1161/01.HYP.0000047240.33861.6B Alonso-Galicia, 2002, Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II, Am J Physiol Regul Integr Comp Physiol, 283, R60, 10.1152/ajpregu.00664.2001 Chabova, 2007, Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats, Vascul Pharmacol, 47, 145, 10.1016/j.vph.2007.05.005 Guo, 2007, Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation, J Pharmacol Exp Ther, 321, 18, 10.1124/jpet.106.115360 Guo, 2009, 20-HETE can act as a nonhypoxic regulator of HIF-1alpha in human microvascular endothelial cells, Am J Physiol Heart Circ Physiol, 297, H602, 10.1152/ajpheart.00874.2008 Huang, 1996, Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors, J Biol Chem, 271, 15635, 10.1074/jbc.271.26.15635 Ishizaka, 1994, Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta, Circulation, 96, 1923, 10.1161/01.CIR.96.6.1923 Landmesser, 2006, Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide, J Hypertens Suppl, 24, S39, 10.1097/01.hjh.0000220405.38622.23 Mollnau, 2002, Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling, Circ Res, 90, E58, 10.1161/01.RES.0000012569.55432.02 Morgan-Boyd, 1987, Effects of bradykinin and angiotensin II on intracellular Ca2+ dynamics in endothelial cells, Am J Physiol, 253, C588, 10.1152/ajpcell.1987.253.4.C588 Wolf, 1993, Angiotensin II as a hypertrophogenic cytokine for proximal tubular cells, Kidney Int Suppl, 39, S100 Ishizuka, 2008, 20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells, J Pharmacol Exp Ther, 324, 103, 10.1124/jpet.107.130336 Sodhi, 2010, CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent, Hypertension, 56, 871, 10.1161/HYPERTENSIONAHA.110.154559 Cheng, 2012, Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction, Arterioscler Thromb Vasc Biol, 32, 1917, 10.1161/ATVBAHA.112.248344 Sacerdoti, 1989, Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats, Science, 243, 388, 10.1126/science.2492116 Dunn, 2008, Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats, Am J Physiol Heart Circ Physiol, 295, H2455, 10.1152/ajpheart.00512.2008 Holla, 2001, Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension, Proc Natl Acad Sci U S A, 98, 5211, 10.1073/pnas.081627898 Wu, 2011, Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase, Hypertension, 57, 788, 10.1161/HYPERTENSIONAHA.110.161570 Ishizuka, 2004, Role of androgens in the renal production of 20-hydroxyeicosatetraenoic acid in spontaneously hypertensive rats, Nihon Jinzo Gakkai Shi, 46, 685 Inoue, 2009, Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE, Am J Physiol Renal Physiol, 297, F875, 10.1152/ajprenal.00364.2009 Imig, 2010, 20-hydroxyeicosatetraenoic acid and angiotensin: a positive feedback system to cause hypertension, Hypertension, 56, 822, 10.1161/HYPERTENSIONAHA.110.156174 Zhang, 2004, Transfection of CYP4A1 cDNA decreases diameter and increases responsiveness of gracilis muscle arterioles to constrictor stimuli, Am J Physiol Heart Circ Physiol, 287, H1089, 10.1152/ajpheart.00627.2003 Zhang, 2001, Modulation by 20-HETE of phenylephrine-induced mesenteric artery contraction in spontaneously hypertensive and Wistar-Kyoto rats, Hypertension, 38, 1311, 10.1161/hy1201.096116 Zou, 1996, 20-HETE is an endogenous inhibitor of the large-conductance Ca2+-activated K+ channel in renal arterioles, Am J Physiol, 270, R228 Frisbee, 2000, Contribution of cytochrome P-450 omega-hydroxylase to altered arteriolar reactivity with high-salt diet and hypertension, Am J Physiol Heart Circ Physiol, 278, H1517, 10.1152/ajpheart.2000.278.5.H1517 Wang, 2006, Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus, Circ Res, 98, 962, 10.1161/01.RES.0000217283.98806.a6 Joly, 2006, Increased renal vascular reactivity to ANG II after unilateral nephrectomy in the rat involves 20-HETE, Am J Physiol Regul Integr Comp Physiol, 291, R977, 10.1152/ajpregu.00401.2005 Schulz, 2008, Nitric oxide: tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension, Antioxid Redox Signal, 10, 1115, 10.1089/ars.2007.1989 Ignarro, 1990, Biosynthesis and metabolism of endothelium-derived nitric oxide, Annu Rev Pharmacol Toxicol, 30, 535, 10.1146/annurev.pa.30.040190.002535 Cai, 2000, Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress, Circ Res, 87, 840, 10.1161/01.RES.87.10.840 Harrison, 1997, Cellular and molecular mechanisms of endothelial cell dysfunction, J Clin Invest, 100, 2153, 10.1172/JCI119751 Frisbee, 2000, Contribution of cytochrome P-450 omega-hydroxylase to altered arteriolar reactivity with high-salt diet and hypertension, Am J Physiol Heart Circ Physiol, 278, H1517, 10.1152/ajpheart.2000.278.5.H1517 Schuck, 2013, Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients, Atherosclerosis, 227, 442, 10.1016/j.atherosclerosis.2013.01.034 Ward, 2004, Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans, Circulation, 110, 438, 10.1161/01.CIR.0000136808.72912.D9 Ward, 2005, Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects, Free Radic Biol Med, 38, 1032, 10.1016/j.freeradbiomed.2004.12.024 Cheng, 2008, 20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling, Am J Physiol Heart Circ Physiol, 294, H1018, 10.1152/ajpheart.01172.2007 Jacobs, 2006, VEGF-induced relaxation of pulmonary arteries is mediated by endothelial cytochrome P-450 hydroxylase, Am J Physiol Lung Cell Mol Physiol, 291, L369, 10.1152/ajplung.00265.2004 Maranon, 2013, Sex and gender differences in control of blood pressure, Clin Sci (Lond), 125, 311, 10.1042/CS20130140 Holla, 2001, Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension, Proc Natl Acad Sci U S A, 98, 5211, 10.1073/pnas.081627898 Ding, 2013, 20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension, Am J Physiol Renal Physiol, 305, F753, 10.1152/ajprenal.00292.2013 Zhang, 2008, The role of inflammatory cytokines in endothelial dysfunction, Basic Res Cardiol, 103, 398, 10.1007/s00395-008-0733-0 Cheng, 2014, Vascular characterization of mice with endothelial expression of cytochrome P450 4F2, FASEB J, 28, 2915, 10.1096/fj.13-241927 Lemarie, 2010, Extracellular matrix alterations in hypertensive vascular remodeling, J Mol Cell Cardiol, 48, 433, 10.1016/j.yjmcc.2009.09.018 Intengan, 2001, Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis, Hypertension, 38, 581, 10.1161/hy09t1.096249 Ooshima, 1974, Increased collagen synthesis in blood vessels of hypertensive rats and its reversal by antihypertensive agents, Proc Natl Acad Sci U S A, 71, 3019, 10.1073/pnas.71.8.3019 Udenfriend, 1976, Increased formation of collagen in the blood vessels of hypertensive rats, Ann N Y Acad Sci, 275, 101, 10.1111/j.1749-6632.1976.tb43343.x Spector, 1978, Increased vascular collagen biosynthesis by hypertension and reversal by antihypertensive drugs, Blood Vessels, 15, 176 Ooshima, 1977, Collagen metabolism in blood vessels of hypertensive rats, Jpn Circ J, 41, 912, 10.1253/jcj.41.912 Ooshima, 1975, Collagen biosynthesis in blood vessels of brain and other tissues of the hypertensive rat, Science, 190, 898, 10.1126/science.171771 Marchesi, 2008, Role of the renin-angiotensin system in vascular inflammation, Trends Pharmacol Sci, 29, 367, 10.1016/j.tips.2008.05.003 Wu, 2013, Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE Synthase, J Am Soc Nephrol, 10.1681/ASN.2012070714 Issan, 2013, Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia, Prostaglandins Other Lipid Mediat, 100–101, 15, 10.1016/j.prostaglandins.2012.12.002 Li, 2014, 20-Hydroxyeicosatetraenoic acid impairs endothelial insulin signaling by inducing phosphorylation of the insulin receptor substrate-1 at Ser616, PLOS ONE, 9, e95841, 10.1371/journal.pone.0095841 Eid, 2013, 20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway, PLoS ONE, 8, e70029, 10.1371/journal.pone.0070029 Eid, 2013, Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy, J Biol Regul Homeost Agents, 27, 693 Gangadhariah, 2014, Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy, J Am Soc Nephrol Hoff, 2011, Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury, Kidney Int, 79, 57, 10.1038/ki.2010.377 Liu, 2014, The protective effect of HET0016 on brain edema and blood-brain barrier dysfunction after cerebral ischemia/reperfusion, Brain Res, 1544, 45, 10.1016/j.brainres.2013.11.031 Orozco, 2013, 20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries, J Pharmacol Exp Ther, 346, 67, 10.1124/jpet.113.203844 Toth, 2013, Treatment with the cytochrome P450 omega-hydroxylase inhibitor HET0016 attenuates cerebrovascular inflammation: oxidative stress and improves vasomotor function in spontaneously hypertensive rats, Br J Pharmacol, 168, 1878, 10.1111/bph.12079 Carmeliet, 2011, Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases, Nat Rev Drug Discov, 10, 417, 10.1038/nrd3455 Risau, 1997, Mechanisms of angiogenesis, Nature, 386, 671, 10.1038/386671a0 Gerhardt, 2003, VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia, J Cell Biol, 161, 1163, 10.1083/jcb.200302047 Hellstrom, 2007, Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis, Nature, 445, 776, 10.1038/nature05571 Siekmann, 2007, Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries, Nature, 445, 781, 10.1038/nature05577 Lee, 2011, Ups and downs of guided vessel sprouting: the role of polarity, Physiology (Bethesda), 26, 326, 10.1152/physiol.00018.2011 Lizama, 2013, Polarizing pathways: balancing endothelial polarity, permeability, and lumen formation, Exp Cell Res, 319, 1247, 10.1016/j.yexcr.2013.03.028 Horvat, 1986, Endothelial cell membranes contain podocalyxin – the major sialoprotein of visceral glomerular epithelial cells, J Cell Biol, 102, 484, 10.1083/jcb.102.2.484 Iruela-Arispe, 2009, Cellular and molecular mechanisms of vascular lumen formation, Dev Cell, 16, 222, 10.1016/j.devcel.2009.01.013 Strilic, 2009, The molecular basis of vascular lumen formation in the developing mouse aorta, Dev Cell, 17, 505, 10.1016/j.devcel.2009.08.011 Chen, 2005, Inhibitors of cytochrome P450 4A suppress angiogenic responses, Am J Pathol, 166, 615, 10.1016/S0002-9440(10)62282-1 Chen, 2012, 20-HETE in neovascularization, Prostaglandins Other Lipid Mediat, 98, 63, 10.1016/j.prostaglandins.2011.12.005 Dhanasekaran, 2009, 20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cells, Am J Physiol Heart Circ Physiol, 296, H777, 10.1152/ajpheart.01087.2008 Medhora, 2008, 20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells, Am J Physiol Lung Cell Mol Physiol, 294, L902, 10.1152/ajplung.00278.2007 Yu, 2011, Cytochrome P450 omega-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer, Cancer Chemother Pharmacol, 68, 619, 10.1007/s00280-010-1521-8 Yu, 2012, Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer, Toxicol Appl Pharmacol, 264, 73, 10.1016/j.taap.2012.07.019 Alexanian, 2013, Targeting 20-HETE producing enzymes in cancer - rationale, pharmacology, and clinical potential, Onco Targets Ther, 6, 243